Washington, D.C. – U.S. Reps.
WASHINGTON, DC – Vital innovations in biomedical research are within reach, potentially saving countless lives, with the House about to debate its final version of the bipartisan 21st Century Cures Act, Congresswoman Diana DeGette (D-CO) said.
Denver, CO – With families in Colorado and across the country about to hit the roads for the holiday season, Congresswoman Diana DeGette (D-CO) has renewed her push for authorities to overhaul an outdated federal standard governing car seatback safety and require that the government be notified whenever death or injuries from seatback collapses occur.
Denver – Senator Jeff Sessions should not be nominated to serve as the nation’s next attorney general due to his regressive views, said Congresswoman Diana DeGette (D-CO).
Washington, DC – Congresswoman Diana DeGette (D-CO) joined fellow House Democrats in calling for President-elect Trump to reverse the appointment of Steve Bannon as his chief strategist.
Washington, DC -- Congresswoman Diana DeGette (D-CO), who serves as Chief Deputy Whip, today issued the following statement about personnel choices made and actions taken as the Trump presidency takes shape:
House Energy and Commerce Committee members Diana DeGette (D-CO) and Susan Brooks (R-IN) today asked the U.S. Food and Drug Administration for information about how the agency is working to address potential cybersecurity vulnerabilities in medical devices.
Washington, DC – More than 20 members of Congress who are engaged in women’s health care issues today called on the Obama administration to enhance health providers’ training on women’s contraception options.
Denver, CO – Congresswoman Diana DeGette helped secure a $1.35 million grant, announced today, enabling Denver and the Regional Transportation District to improve service to riders by studying transit oriented development (TOD).
Washington, DC – On behalf of the Congressional Diabetes Caucus, co-chairs Diana DeGette (D-CO) and Tom Reed (R-NY) hailed as a major breakthrough today’s approval by the Food and Drug Administration of a first-ever commercial version of an artificial pancreas system to improve the treatment of type 1 diabetes.